Skip to main content
Close
Home
Society of Hospital Medicine
Presented by Society of Hospital Medicine
Home
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

Sharon Worcester

Sharon Worcester is an award-winning medical journalist for MDedge News. She has been with the company since 1996, first as the Southeast Bureau Chief (1996-2009) when the company was known as International Medical News Group, then as a freelance writer (2010-2015) before returning as a reporter in 2015. She previously worked as a daily newspaper reporter covering health and local government. Sharon currently reports primarily on oncology and hematology. She has a BA from Eckerd College and an MA in Mass Communication/Print Journalism from the University of Florida. Connect with her via LinkedIn and follow her on twitter @SW_MedReporter.

News

Adding oxaliplatin improves OS, DFS in MSI colon cancer

Author:
Sharon Worcester
Publish date: March 31, 2021

Adding oxaliplatin to fluoropyrimidine should be the standard of care adjuvant treatment in this setting....

  • Read More

News

Poor survival with COVID in patients who have had HSCT

Author:
Sharon Worcester
Publish date: March 26, 2021

The probability of survival 30 days after being diagnosed with COVID-19 is only 68% for persons who have...

  • Read More

News

Study: Gynecologic cancer therapy does not increase COVID-19 risks

Author:
Sharon Worcester
Publish date: March 22, 2021

Recent anticancer therapy was not associated with COVID-19 hospitalization or mortality in patients with...

  • Read More

News

Intervention reduced racial disparities among patients in cancer trials

Author:
Sharon Worcester
Publish date: March 21, 2021

A navigation program improved outcomes of Black women with endometrial cancer enrolled in clinical trials.

  • Read More

News

Andecaliximab disappoints in advanced gastric cancer

Author:
Sharon Worcester
Publish date: March 9, 2021

There was no improvement in survival when andecaliximab was added to first-line treatment with modified oxaliplatin, leucovorin, and fluorouracil...

  • Read More

News

Breast cancer mortality in under 40s resparks screening debate

Author:
Sharon Worcester
Publish date: March 5, 2021

An increase in breast cancer mortality among women younger than 40 highlights the value of regular screening,...

  • Read More

News

New ASH guidelines: VTE prevention and treatment in cancer patients

Author:
Sharon Worcester
Publish date: March 2, 2021

The purpose of the guidelines is to provide clinical decision support for shared decision-making by cancer...

  • Read More

News

Detailed glioblastoma map could lead to better treatment approaches

Author:
Sharon Worcester
Publish date: February 22, 2021

The identification of multiple glioblastoma tumor subtypes may explain negative findings in trials of...

  • Read More

News

Pap test/cervical swab samples can reveal ovarian cancer biomarkers

Author:
Sharon Worcester
Publish date: February 22, 2021

Pap test screening is widely accepted, suggesting the value of developing it as a screening tool for both...

  • Read More

News

Novel ddPCR assay precisely measures CAR T-cells after infusion

Author:
Sharon Worcester
Publish date: February 22, 2021

The ddPCR assay is particularly useful for assessing whether low CAR T-cell levels on flow cytometry are...

  • Read More

News

CAR T-cell products shine in real-world setting, reveal new insights

Author:
Sharon Worcester
Publish date: February 18, 2021

Real-world CAR-T experience provides new insights for predicting outcomes in patients with DLBCL.

  • Read More

News

TITAN: Final results confirm apalutamide benefit in mCSPC

Author:
Sharon Worcester
Publish date: February 13, 2021

Apalutamide reduced the risk of death by 35% overall and 48% when accounting for crossover.

  • Read More

News

Declines in PSA screening may account for rise in metastatic prostate cancers

Author:
Sharon Worcester
Publish date: February 12, 2021

Longitudinal reductions in PSA screening across U.S. states were associated with increased incidence of metastatic prostate cancer.

  • Read More

News

FDA okays new CAR T-cell treatment for large B-cell lymphomas

Author:
Sharon Worcester
Publish date: February 8, 2021

The Food and Drug Administration has approved lisocabtagene maraleucel (Breyanzi), a chimeric antigen receptor (...

  • Read More

News

FDA grants MET inhibitor tepotinib accelerated approval for NSCLC

Author:
Sharon Worcester
Publish date: February 4, 2021

Tepotinib is the first once-daily oral MET inhibitor approved for this patient population.

  • Read More

Pages

  • « first
  • …
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • last »
An Official Publication of the Society of Hospital Medicine

Society of Hospital Medicine
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

Copyright  © 2023 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Menu Close